Fig. 2From: Significant suppression of radiation dermatitis in breast cancer patients using a topically applied adrenergic vasoconstrictorSubject 2000. A, NG12-1 treatment area (arrows) showing skin blanch 20 min after topical NG12-1 application. B, NG12-1 treatment area (arrows) showing reduced radiodermatis on Day 38. The interim analysis score was ++Back to article page